Clinical Trial Update: A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, crossover trial evaluating oral glutamine to suppress frequently recurrent herpes labialis; the study was terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis
• Herpes Simplex Virus Infections

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Labialis, Herpes Simplex Virus | Phase 2 | Status: TERMINATED | Results posted: 2012-06-11